Wissen schafft Heilung.

 

Wissenschaftliche Publikationen von Prof. Dr. med. Michael Ulbig

1. [Ophthalmological assessment in procedures for disability benefits for the blind : Why medical certificates alone are insufficient].
von Livonius B, Pause H, Ulbig M.
Ophthalmologe. 2015 Dec 17. [Epub ahead of print] German.
PMID: 26679500

2. Diabetic retinopathy - ocular complications of diabetes mellitus.
Nentwich MM, Ulbig MW.
World J Diabetes. 2015 Apr 15;6(3):489-99. doi: 10.4239/wjd.v6.i3.489. Review.
PMID: 25897358

3. Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema.
Liegl R, Langer J, Seidensticker F, Reznicek L, Haritoglou C, Ulbig MW, Neubauer AS, Kampik A, Kernt M.
PLoS One. 2014 Dec 26;9(12):e113981. doi: 10.1371/journal.pone.0113981. eCollection 2014.
PMID: 25541960

4. Spironolactone in the treatment of central serous chorioretinopathy - a case series.
Herold TR, Prause K, Wolf A, Mayer WJ, Ulbig MW.
Graefes Arch Clin Exp Ophthalmol. 2014 Dec;252(12):1985-91. doi: 10.1007/s00417-014-2780-6. Epub 2014 Aug 20.
PMID: 25138605

5. Assessment of ß-zone peripapillary atrophy by optical coherence tomography and scanning laser ophthalmoscopy imaging in glaucoma patients.
Seidensticker F, Reznicek L, Mann T, Hübert I, Kampik A, Ulbig M, Hirneiss C, Neubauer AS, Kernt M.
Clin Ophthalmol. 2014 Jun 27;8:1233-9. doi: 10.2147/OPTH.S55751. eCollection 2014.
PMID: 25061270

6. [Choroidal tumor with accompanying papilledema].
Mäueler TJ, Ulbig M, Eibl-Lindner KH.
Ophthalmologe. 2014 Sep;111(9):876-8. doi: 10.1007/s00347-014-3076-2. German. No abstract available.
PMID: 24938367

7. Visual acuity and central retinal thickness: fulfilment of retreatment criteria for recurrent neovascular AMD in routine clinical care.
Reznicek L, Muhr J, Ulbig M, Kampik A, Mayer WJ, Haritoglou C, Neubauer A, Wolf A.
Br J Ophthalmol. 2014 Oct;98(10):1333-7. doi: 10.1136/bjophthalmol-2013-304399. Epub 2014 Jun 5.
PMID: 24903670

8. Scanning laser 'en face' retinal imaging of epiretinal membranes.
Reznicek L, Dabov S, Kayat B, Liegl R, Kampik A, Ulbig M, Kernt M.
Saudi J Ophthalmol. 2014 Apr;28(2):134-8. doi: 10.1016/j.sjopt.2014.03.009. Epub 2014 Mar 24.
PMID: 24843307

9. Central serous chorioretinopathy.
Liegl R, Ulbig MW.
Ophthalmologica. 2014;232(2):65-76. doi: 10.1159/000360014. Epub 2014 Apr 26. Review.
PMID: 24776999

10. Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis--potential role as biomarker of response to ranibizumab treatment.
Leicht SF, Kernt M, Neubauer A, Wolf A, Oliveira CM, Ulbig M, Haritoglou C.
Ophthalmologica. 2014;231(4):198-203. doi: 10.1159/000357505. Epub 2014 Mar 19.
PMID: 24662930

11. Response to Hernández-Martínez et al.
Mayer WJ, Wolf A, Kernt M, Kook D, Kampik A, Ulbig M, Haritoglou C.
Eye (Lond). 2014 Mar;28(3):362. doi: 10.1038/eye.2013.261. Epub 2013 Dec 20. No abstract available. Erratum in: Eye (Lond). 2014 Mar;28(3):366.
PMID: 24357846

12. Nonmydriatic ultra-wide-field scanning laser ophthalmoscopy (Optomap) versus two-field fundus photography in diabetic retinopathy.
Liegl R, Liegl K, Ceklic L, Haritoglou C, Kampik A, Ulbig MW, Kernt M, Neubauer AS.
Ophthalmologica. 2014;231(1):31-6. doi: 10.1159/000355092. Epub 2013 Nov 13.
PMID: 24247157

13. [Wide-field fundus autofluorescence in non-infectious posterior uveitis].
Reznicek L, Seidensticker F, Stumpf C, Langer J, Thurau S, Ulbig MW, Kampik A, Neubauer A, Kernt M.
Ophthalmologe. 2014 Jun;111(6):543-7. German.
PMID: 24121877

14. [Young patient with acute monolateral amaurosis].
Rueping J, Kramer M, Kook D, Kampik A, Ulbig M, Haritoglou C.
Ophthalmologe. 2014;111(7):664-6. doi: 10.1007/s00347-013-2903-1. German.
PMID: 23958835

15. [Diffusely margined papilla of unclear origin in a 30-year-old patient].
Kortüm KU, Bräg A, Kampik A, Ulbig M.
Ophthalmologe. 2014 Jan;111(1):61-4. doi: 10.1007/s00347-013-2895-x. German. No abstract available.
PMID:23873399

16. Traumatic retinopathy presenting as acute macular neuroretinopathy.
Nentwich MM, Leys A, Cramer A, Ulbig MW.
Br J Ophthalmol. 2013 Oct;97(10):1268-72. doi: 10.1136/bjophthalmol-2013-303354. Epub 2013 Jul 12.
PMID: 23853167

17. [Paracentral retinal changes].
Nentwich MM, Ulbig M.
Klin Monbl Augenheilkd. 2013 Oct;230(10):1034-5. doi: 10.1055/s-0032-1328615. Epub 2013 Jul 11. German. No abstract available.
PMID: 23846325

18. Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy.
Haritoglou C, Kernt M, Neubauer A, Gerss J, Oliveira CM, Kampik A, Ulbig M.
Retina. 2014 Jan;34(1):157-64. doi: 10.1097/IAE.0b013e318295f6de.
PMID: 23792485

19. [Navigated retinal laser therapy].
Kernt M, Ulbig M, Kampik A, Neubauer AS.
Ophthalmologe. 2013 Aug;110(8):776-82. doi: 10.1007/s00347-013-2868-0. German.
PMID: 23760425

20. [Peripheral fine granular retinal pigmentation in combination with macular gliosis].
Nentwich MM, Ulbig MW.
Ophthalmologe. 2013 Oct;110(10):982-5. doi: 10.1007/s00347-013-2862-6. German. No abstract available.
PMID: 23740159

21. Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio.
Kernt M, Arend N, Buerger A, Mann T, Haritoglou C, Ulbig MW, Kampik A, Hirneiss C.
J Glaucoma. 2013 Jun-Jul;22(5):404-12. doi: 10.1097/IJG.0b013e31824caf90.
PMID: 23661043

22. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L, Cserhati S, Seidensticker F, Liegl R, Kampik A, Ulbig M, Neubauer AS, Kernt M.
Acta Ophthalmol. 2013 Nov;91(7):e529-36. doi: 10.1111/aos.12153. Epub 2013 May 7.
PMID: 23647578

23. Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab.
Wolf A, Rüping J, Neubauer AS, Mayer W, Ulbig M, Haritoglou C, Holz FG, Eter N, Kampik A.
Retina. 2013 Oct;33(9):1843-9. doi: 10.1097/IAE.0b013e318287d9be.
PMID: 23598795

24. Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion.
Mayer WJ, Wolf A, Kernt M, Kook D, Kampik A, Ulbig M, Haritoglou C.
Eye (Lond). 2013 Jul;27(7):816-22. doi: 10.1038/eye.2013.79. Epub 2013 Apr 19.
PMID: 23598674

25. [Ranibizumab in diabetic macular edema. Evaluation of functional and morphological aspects].
Reznicek L, Cserhati S, Liegl R, Seidensticker F, Haritoglou C, Wolf A, Kampik A, Ulbig MW, Neubauer A, Kernt M.
Ophthalmologe. 2013 Jul;110(7):645-53. doi: 10.1007/s00347-012-2714-9. German.
PMID: 23436196

26. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
Kernt M, Cserhati S, Seidensticker F, Liegl R, Kampik A, Neubauer A, Ulbig MW, Reznicek L.
Diabetes Res Clin Pract. 2013 Apr;100(1):e11-3. doi: 10.1016/j.diabres.2013.01.006. Epub 2013 Feb 5.
PMID: 23391744

27. Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser.
Neubauer AS, Langer J, Liegl R, Haritoglou C, Wolf A, Kozak I, Seidensticker F, Ulbig M, Freeman WR, Kampik A, Kernt M.
Clin Ophthalmol. 2013;7:121-8. doi: 10.2147/OPTH.S38559. Epub 2013 Jan 16.
PMID: 23345966

28. [Evaluation of Web-based software applications for administrating and organising an ophthalmological clinical trial site].
Kortüm K, Reznicek L, Leicht S, Ulbig M, Wolf A.
Klin Monbl Augenheilkd. 2013 Jul;230(7):715-20. doi: 10.1055/s-0032-1328096. Epub 2013 Jan 20. German.
PMID: 23335082

29. [Improvement of fixation in diabetic macular oedema patients under intravitreal ranibizumab treatment].
Seidensticker F, Reznicek L, Cserhati S, Liegl RG, Langer J, Wolf A, Kampik A, Ulbig M, Haritoglou C, Kernt M.
Klin Monbl Augenheilkd. 2013 May;230(5):524-9. doi: 10.1055/s-0032-1327930. Epub 2012 Dec 10. German.
PMID: 23229224

30. [Treatment of recurrent neovascular age-related macular degeneration with ranibizumab according to the PrONTO scheme].
Wolf A, Reznicek L, Muhr J, Ulbig M, Kampik A, Haritoglou C.
Ophthalmologe. 2013 Aug;110(8):740-5. doi: 10.1007/s00347-012-2717-6. German.
PMID: 23224125

31. The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.
Nentwich MM, Ulbig MW.
Dtsch Arztebl Int. 2012 Sep;109(37):584-90. doi: 10.3238/arztebl.2012.0584. Epub 2012 Sep 14. Review.
PMID: 23093988

32. Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography.
Kernt M, Hadi I, Pinter F, Seidensticker F, Hirneiss C, Haritoglou C, Kampik A, Ulbig MW, Neubauer AS.
Diabetes Care. 2012 Dec;35(12):2459-63. doi: 10.2337/dc12-0346. Epub 2012 Aug 21.
PMID: 22912430

33.
Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C.
Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.
PMID: 22739239

34. [Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema].
Kernt M, Cheuteu R, Liegl RG, Seidensticker F, Cserhati S, Hirneiss C, Haritoglou C, Kampik A, Ulbig M, Neubauer AS.
Ophthalmologe. 2012 Jul;109(7):692-8. doi: 10.1007/s00347-012-2559-2. German.
PMID: 22532038

35. Non-mydriatic wide field fundus photography in bilateral serous retinal detachment due to HELLP syndrome.
Mayer WJ, Hakim I, Ulbig MW, Kernt M, Haritoglou C.
Arch Gynecol Obstet. 2012 Sep;286(3):819-20. doi: 10.1007/s00404-012-2343-1. Epub 2012 Apr 24. No abstract available.
PMID: 22526454

36. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
Kernt M, Thiele S, Neubauer AS, Koenig S, Hirneiss C, Haritoglou C, Ulbig MW, Kampik A.
Retina. 2012 Sep;32(8):1652-63. doi: 10.1097/IAE.0b013e318240a558.
PMID: 22466477

37. Peripheral fundus autofluorescence is increased in age-related macular degeneration.
Reznicek L, Wasfy T, Stumpf C, Kampik A, Ulbig M, Neubauer AS, Kernt M.
Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2193-8. doi: 10.1167/iovs.11-8483.
PMID: 22410571

38. Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas).
Kernt M, Cheuteu RE, Cserhati S, Seidensticker F, Liegl RG, Lang J, Haritoglou C, Kampik A, Ulbig MW, Neubauer AS.
Clin Ophthalmol. 2012;6:289-96. doi: 10.2147/OPTH.S27859. Epub 2012 Feb 27.
PMID: 22393280

39. Axitinib modulates hypoxia-induced blood-retina barrier permeability and expression of growth factors.
Kernt M, Thiele S, Liegl RG, Kernt B, Eibl K, Haritoglou C, Ulbig MW, Kampik A.
Growth Factors. 2012 Feb;30(1):49-61. doi: 10.3109/08977194.2011.639300. Epub 2011 Dec 15.
PMID: 22168366

40. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
Mayer WJ, Hakim I, Haritoglou C, Gandorfer A, Ulbig M, Kampik A, Wolf A.
Acta Ophthalmol. 2013 May;91(3):274-8. doi: 10.1111/j.1755-3768.2011.02264.x. Epub 2011 Sep 22.
PMID: 21952010

41. Alpha-lipoic acid for the prevention of diabetic macular edema.
Haritoglou C, Gerss J, Hammes HP, Kampik A, Ulbig MW; RETIPON Study Group.
Ophthalmologica. 2011;226(3):127-37. doi: 10.1159/000329470. Epub 2011 Jul 29.
PMID: 21811051

42. Filtering blue light reduces light-induced oxidative stress, senescence and accumulation of extracellular matrix proteins in human retinal pigment epithelium cells.
Kernt M, Walch A, Neubauer AS, Hirneiss C, Haritoglou C, Ulbig MW, Kampik A.
Clin Experiment Ophthalmol. 2012 Jan-Feb;40(1):e87-97. doi: 10.1111/j.1442-9071.2011.02620.x. Epub 2011 Aug 18.
PMID: 21668780

43. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma.
Wolf A, von Jagow B, Ulbig M, Haritoglou C.
Ophthalmologica. 2011;226(2):51-6. doi: 10.1159/000327364. Epub 2011 May 5.
PMID: 21546781

44. [The role of light in the developement of RPE degeneration in AMD and potential cytoprotection of minocycline].
Kernt M, Thiele S, Hirneiss C, Neubauer AS, Lackerbauer CA, Ulbig MW, Kampik A.
Klin Monbl Augenheilkd. 2011 Oct;228(10):892-9. doi: 10.1055/s-0029-1245892. Epub 2011 Mar 23. German.
PMID: 21432767

45. In vivo characterization of ischemic retina in diabetic retinopathy.
Reznicek L, Kernt M, Haritoglou C, Kampik A, Ulbig M, Neubauer AS.
Clin Ophthalmol. 2010 Dec 30;5:31-5. doi: 10.2147/OPTH.S13850.
PMID: 21311655

46. [Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium].
Kernt M, Thiele S, Hirneiss C, Neubauer AS, Lackerbauer CA, Wolf A, Eibl KH, Haritoglou C, Ulbig MW, Kampik A.
Ophthalmologe. 2011 May;108(5):445-51. doi: 10.1007/s00347-010-2304-7. German.
PMID: 21253747

47. Correlation of leaking microaneurysms with retinal thickening in diabetic retinopathy.
Reznicek L, Kernt M, Haritoglou C, Ulbig M, Kampik A, Neubauer AS.
Int J Ophthalmol. 2011;4(3):269-71. doi: 10.3980/j.issn.2222-3959.2011.03.11. Epub 2011 Jun 18.
PMID: 22553659

48. Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF.
Kernt M, Neubauer AS, Liegl RG, Hirneiss C, Alge CS, Wolf A, Ulbig MW, Kampik A.
Br J Ophthalmol. 2010 Nov;94(11):1533-9. doi: 10.1136/bjo.2010.182162.
PMID: 20962354

49. Focal and panretinal photocoagulation with a navigated laser (NAVILAS®).
Kernt M, Cheuteu R, Vounotrypidis E, Haritoglou C, Kampik A, Ulbig MW, Neubauer AS.
Acta Ophthalmol. 2011 Dec;89(8):e662-4. doi: 10.1111/j.1755-3768.2010.02017.x. Epub 2010 Oct 14. No abstract available.
PMID: 20946326

50. Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap).
Kernt M, Schaller UC, Stumpf C, Ulbig MW, Kampik A, Neubauer AS.
Clin Ophthalmol. 2010 Jul 30;4:829-36.
PMID: 20689737

51. [Diabetic retinopathy: comparison of the diagnostic features of ultra-widefield scanning laser ophthalmoscopy Optomap with ETDRS 7-field fundus photography].
Kernt M, Pinter F, Hadi I, Hirneiss C, Haritoglou C, Kampik A, Ulbig MW, Neubauer AS.
Ophthalmologe. 2011 Feb;108(2):117-23. doi: 10.1007/s00347-010-2226-4. German.
PMID: 20683601

52. Indocyanine green increases light-induced oxidative stress, senescence, and matrix metalloproteinases 1 and 3 in human RPE cells.
Kernt M, Hirneiss C, Wolf A, Liegl R, Rueping J, Neubauer A, Alge C, Ulbig M, Gandorfer A, Kampik A, Haritoglou C.
Acta Ophthalmol. 2012 Sep;90(6):571-9. doi: 10.1111/j.1755-3768.2010.01961.x. Epub 2010 Jul 29.
PMID: 20670344

53. Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.
Kernt M, Neubauer AS, Eibl KH, Wolf A, Ulbig MW, Kampik A, Hirneiss C.
Clin Ophthalmol. 2010 Jul 21;4:591-604.
PMID: 20668721

54. Coenzyme Q10 prevents human lens epithelial cells from light-induced apoptotic cell death by reducing oxidative stress and stabilizing BAX / Bcl-2 ratio.
Kernt M, Hirneiss C, Neubauer AS, Ulbig MW, Kampik A.
Acta Ophthalmol. 2010 May;88(3):e78-86. doi: 10.1111/j.1755-3768.2010.01875.x. Epub 2010 Apr 1.
PMID: 20374575

55. Images in cardiovascular medicine. Wide-field scanning laser ophthalmoscope imaging and angiography of central retinal vein occlusion.
Kernt M, Ulbig MW.
Circulation. 2010 Mar 30;121(12):1459-60. doi: 10.1161/CIR.0b013e3181d99c22. No abstract available.
PMID: 20351304

56. [Long-term experience of a pseudo-accommodative lens].
Seidensticker F, Schaumberger M, Ulbig M, Ludwig K, Kampik A, Lackerbauer CA.
Klin Monbl Augenheilkd. 2010 Jun;227(6):483-8. doi: 10.1055/s-0028-1109956. Epub 2010 Mar 9. German.
PMID: 20217634

57. Diabetic retinopathy: Early diagnosis and effective treatment.
Kollias AN, Ulbig MW.
Dtsch Arztebl Int. 2010 Feb;107(5):75-83; quiz 84. doi: 10.3238/arztebl.2010.0075. Epub 2010 Feb 5. Review.
PMID: 20186318

58. Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor.
Kernt M, Liegl RG, Rueping J, Neubauer AS, Haritoglou C, Lackerbauer CA, Eibl KH, Ulbig MW, Kampik A.
Growth Factors. 2010 Jun;28(3):211-20. doi: 10.3109/08977191003604505.
PMID: 20166888

59. Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema.
Kreutzer TC, Al Saeidi R, Kook D, Wolf A, Ulbig MW, Neubauer AS, Haritoglou C.
Ophthalmologica. 2010;224(4):258-64. doi: 10.1159/000284466. Epub 2010 Feb 17.
PMID: 20160463

60. [Laser embolectomy for central retinal artery occlusion].
Haritoglou C, Wolf A, Ulbig MW.
Ophthalmologe. 2010 May;107(5):465-7. doi: 10.1007/s00347-009-2078-y. German.
PMID: 20024564

61. Amadeus II microkeratome: optimizing microkeratome settings for high flap accuracy using optical low coherence reflectometry.
Lackerbauer CA, Kollias A, Kreutzer TC, Ulbig M, Kampik A, Grueterich M.
Eur J Ophthalmol. 2010 Jan-Feb;20(1):41-7.
PMID: 19924667

62. Two-step LASIK after penetrating keratoplasty.
Kollias AN, Schaumberger MM, Kreutzer TC, Ulbig MW, Lackerbauer CA.
Clin Ophthalmol. 2009;3:581-6. Epub 2009 Nov 2.
PMID: 19898662

63. Customizing the Amadeus II microkeratome: evaluation of cut quality with various settings using electron microscopy.
Lackerbauer CA, Grueterich M, Kojetinsky C, Ulbig M, Kollias A.
Eur J Ophthalmol. 2009 Sep-Oct;19(5):743-7.
PMID: 19787592

64. [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].
Kernt M, Hirneiss C, Neubauer AS, Liegl RG, Eibl KH, Wolf A, de Kaspar H, Ulbig MW, Kampik A.
Ophthalmologe. 2010 Aug;107(8):720-7. doi: 10.1007/s00347-009-2027-9. German.
PMID: 19756636

65. Correlation between estimated and measured corneal ablation and refractive outcomes in laser in situ keratomileusis for myopia.
Lackerbauer CA, Grüterich M, Ulbig M, Kampik A, Kojetinsky C.
J Cataract Refract Surg. 2009 Aug;35(8):1343-7. doi: 10.1016/j.jcrs.2009.03.030.
PMID: 19631118

66. [Protective effect of blue light-absorbing IOLs on the human retinal pigment epithelium].
Kernt M, Hirneiss C, Neubauer AS, Lackerbauer CA, Eibl KH, Wolf A, Ulbig M, Kampik A.
Ophthalmologe. 2010 Feb;107(2):150-7. doi: 10.1007/s00347-009-1945-x. German.
PMID: 19499230

67. Intracameral moxifloxacin: in vitro safety on human ocular cells.
Kernt M, Neubauer AS, Liegl RG, Lackerbauer CA, Eibl KH, Alge CS, Ulbig MW, A AK.
Cornea. 2009 Jun;28(5):553-61. doi: 10.1097/ICO.0b013e318191447b.
PMID: 19421040

68. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Haritoglou C, Gerss J, Sauerland C, Kampik A, Ulbig MW; CALDIRET study group.
Lancet. 2009 Apr 18;373(9672):1364-71. doi: 10.1016/S0140-6736(09)60218-X.
PMID: 19376452

69. Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression.
Kernt M, Neubauer AS, Liegl R, Eibl KH, Alge CS, Lackerbauer CA, Ulbig MW, Kampik A.
J Cataract Refract Surg. 2009 Feb;35(2):354-62. doi: 10.1016/j.jcrs.2008.10.052.
PMID: 19185255

70. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48.
PMID: 18779710

71. [Anti-VEGF treatment for retinal angiomatous proliferation].
Wolf A, Kook D, Kreutzer T, Gandorfer A, Haritoglou C, Kampik A, Ulbig M.
Ophthalmologe. 2008 Sep;105(9):845-51. doi: 10.1007/s00347-008-1785-0. German.
PMID: 18607601

72. [Sudden loss of vision].
Kollias A, Thurau S, Eibl K, Ulbig MW.
Ophthalmologe. 2008 Sep;105(9):856-9. doi: 10.1007/s00347-007-1685-8. German. No abstract available.
PMID: 18415105

73. In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment.
Kernt M, Neubauer AS, Ulbig MW, Kampik A, Welge-Lüssen U.
J Cataract Refract Surg. 2008 Mar;34(3):480-8. doi: 10.1016/j.jcrs.2007.10.046.
PMID: 18299076

74. Epi-LASIK using the Amadeus II microkeratome: evaluation of cut quality using light and electron microscopy.
Kollias A, Ulbig MW, Spitzlberger GM, Abdallat WH, Froehlich S, Welge-Luessen U, Lackerbauer CA.
J Cataract Refract Surg. 2007 Dec;33(12):2118-21.
PMID: 18053914

75. Bevacizumab and retinal ischemia.
Neubauer AS, Kook D, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW, Ceklic L.
Ophthalmology. 2007 Nov;114(11):2096. No abstract available.
PMID: 17980746

76. Image quality characteristics of a novel colour scanning digital ophthalmoscope (SDO) compared with fundus photography.
Strauss RW, Krieglstein TR, Priglinger SG, Reis W, Ulbig MW, Kampik A, Neubauer AS.
Ophthalmic Physiol Opt. 2007 Nov;27(6):611-8.
PMID: 17956367

77. Digital fundus image grading with the non-mydriatic Visucam(PRO NM) versus the FF450(plus) camera in diabetic retinopathy.
Neubauer AS, Rothschuh A, Ulbig MW, Blum M.
Acta Ophthalmol. 2008 Mar;86(2):177-82. Epub 2007 Oct 18.
PMID: 17944975

78. [Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].
Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW.
Ophthalmologe. 2008 Feb;105(2):158-64. German.
PMID: 17653552

79. Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap).
Neubauer AS, Kernt M, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW.
Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):229-35. Epub 2007 Jul 11.
PMID: 17622548

80. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
Happich M, Breitscheidel L, Meisinger C, Ulbig M, Falkenstein P, Benter U, Watkins J.
Curr Med Res Opin. 2007 Jun;23(6):1367-74. Epub 2007 May 21.
PMID: 17559744

81. The economic burden of diabetic retinopathy in Germany in 2002.
Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J.
Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):151-9. Epub 2007 Apr 4.
PMID: 17406883

82. Laser treatment in diabetic retinopathy.
Neubauer AS, Ulbig MW.
Ophthalmologica. 2007;221(2):95-102. Review.
PMID: 17380063

83. [Artifacts in optical coherence tomography (OCT) imaging of the retina].
Strauss RW, Scholz F, Ulbig MW, Kampik A, Neubauer AS.
Klin Monbl Augenheilkd. 2007 Jan;224(1):47-51. German.
PMID: 17260319

84. Topography of diabetic macular oedema compared with fluorescein angiography.
Neubauer AS, Chryssafis C, Priglinger SG, Haritoglou C, Thiel M, Welge-Lüssen U, Kampik A, Ulbig MW.
Acta Ophthalmol Scand. 2007 Feb;85(1):32-9.
PMID: 17244207

85. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
Retina. 2006 Nov-Dec;26(9):999-1005.
PMID: 17151486

86. Cost utility for penetrating keratoplasty in patients with poor binocular vision.
Hirneiss C, Neubauer AS, Niedermeier A, Messmer EM, Ulbig M, Kampik A.
Ophthalmology. 2006 Dec;113(12):2176-80. Epub 2006 Sep 25.
PMID: 16996598

87. Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.
Krieglstein TR, Kampik A, Ulbig M.
Br J Ophthalmol. 2006 Nov;90(11):1357-60. Epub 2006 Aug 2.
PMID: 16885191

88. [Ocular manisfestations of systemic disease].
Kristin N, Ulbig M.
MMW Fortschr Med. 2006 Jan 12;148(1-2):38-41. German.
PMID: 16610413

89. Peripheral retinal changes in acute retinal necrosis imaged by ultra widefield scanning laser ophthalmoscopy.
Neubauer AS, Yu A, Haritoglou C, Ulbig MW.
Acta Ophthalmol Scand. 2005 Dec;83(6):758-60. No abstract available.
PMID: 16396659

90. [Diplopia after delivery of a child].
Kollias A, Ulbig MW.
Ophthalmologe. 2006 Mar;103(3):228-30. German. No abstract available.
PMID: 15821919

91. [Unilateral temporary vision loss in an otherwise healthy elderly patient].
Kook D, Haritoglou C, Ulbig MW.
Ophthalmologe. 2006 Mar;103(3):224-7. German. No abstract available.
PMID: 15821918

92. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.
Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A.
Am J Ophthalmol. 2005 Apr;139(4):638-52.
PMID: 15808159

93. [Incomplete, incongruent homonymous hemianopsia toward the right].
Eibl KH, Neubauer AS, Kampik A, Ulbig MW.
Ophthalmologe. 2004 Mar;101(3):294-6. German. No abstract available.
PMID: 15007610

94. [Unilateral visual deterioration due to macular tumour of unclear origin. 32-year old female patient with sudden low vision in the right eye].
Mohi S, Thurau SR, Ulbig MW.
Ophthalmologe. 2003 Nov;100(11):984-7. German. No abstract available.
PMID: 14669036

95. Tele-screening for diabetic retinopathy with the retinal thickness analyzer.
Neubauer AS, Welge-Lüssen UC, Thiel MJ, Alge C, Priglinger SG, Hirneiss C, Ulbig MW, Kampik A.
Diabetes Care. 2003 Oct;26(10):2890-7.
PMID: 14514597

96. Bilateral retinal telangiectasia and exudative retinopathy associated with isolated hemihyperplasia.
Haritoglou C, Schmidt H, Rudolph G, Ulbig MW.
Retina. 2003 Aug;23(4):549-52. No abstract available.
PMID: 12972772

97. Comment on the article: Indocyanine-green-assisted internal limiting membrane peeling in macular surgery: a follow-up study.
Haritoglou C, Gandorfer A, Ulbig MW, Kampik A.
Graefes Arch Clin Exp Ophthalmol. 2003 Jul;241(7):598; author reply 599-601. Epub 2003 Apr 16. No abstract available.
PMID: 12698258

98. The effect of indocyanine-green on functional outcome of macular pucker surgery.
Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A.
Am J Ophthalmol. 2003 Mar;135(3):328-37.
PMID: 12614750

99. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation.
Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A.
Am J Ophthalmol. 2002 Dec;134(6):836-41.
PMID: 12470751

100. Long-term follow-up after macular hole surgery with internal limiting membrane peeling.
Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A.
Am J Ophthalmol. 2002 Nov;134(5):661-6.
PMID: 12429240

101. TTT for occult CNV: check the power!
Mueller AJ, Ulbig M, Kampik A.
Br J Ophthalmol. 2002 Oct;86(10):1194. No abstract available.
PMID: 12234913

102. [Diabetic retinopathy. Only early therapy prevents blindness].
Gandorfer A, Ulbig MW.
MMW Fortschr Med. 2002 Jun 27;144(26):37-40. German. No abstract available.
PMID: 12154473

103. Retinal neovascularization in choroidal melanoma without retinal ischemia.
Keunen JE, Hooymans JM, Ulbig MW, Shields CL.
Retina. 2002 Jun;22(3):371-4. No abstract available.
PMID: 12055478

104. Transpupillary thermotherapy (TTT) in circumscribed choroidal hemangioma.
Fuchs AV, Mueller AJ, Grueterich M, Ulbig MW.
Graefes Arch Clin Exp Ophthalmol. 2002 Jan;240(1):7-11. Epub 2001 Nov 22.
PMID: 11954785

105. Macular hole size as a prognostic factor in macular hole surgery.
Ullrich S, Haritoglou C, Gass C, Schaumberger M, Ulbig MW, Kampik A.
Br J Ophthalmol. 2002 Apr;86(4):390-3.
PMID: 11914205

106. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants.
Gandorfer A, Ulbig M, Kampik A.
Eye (Lond). 2002 Jan;16(1):95-7. No abstract available.
PMID: 11913902

107. Scanning laser ophthalmoscope findings in acute macular neuroretinopathy.
Gandorfer A, Ulbig MW.
Am J Ophthalmol. 2002 Mar;133(3):413-5.
PMID: 11860985

108. Comparison of foveal thickness measured with the retinal thickness analyzer and optical coherence tomography.
Neubauer AS, Priglinger S, Ullrich S, Bechmann M, Thiel MJ, Ulbig MW, Kampik A.
Retina. 2001;21(6):596-601.
PMID: 11756882

109. Vitreoretinal morphology of plasmin-treated human eyes.
Gandorfer A, Priglinger S, Schebitz K, Hoops J, Ulbig M, Ruckhofer J, Grabner G, Kampik A.
Am J Ophthalmol. 2002 Jan;133(1):156-9.
PMID: 11755861

110. [Diagnosis and differential diagnosis of the combined hamartoma of the retina and retinal pigment epithelium].
Eibl KH, Mueller AJ, Ulbig MW.
Klin Monbl Augenheilkd. 2001 Nov;218(11):697-701. German.
PMID: 11731896

111. [Bilateral striped fundus change ].
Haritoglou C, Ulbig MW.
Ophthalmologe. 2001 Aug;98(8):772-3. German. No abstract available.
PMID: 11552418

112. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage.
Gandorfer A, Haritoglou C, Gass CA, Ulbig MW, Kampik A.
Am J Ophthalmol. 2001 Sep;132(3):431-3.
PMID: 11530071

113. Central retinal artery occlusion in association with an aneurysm of the internal carotid artery.
Haritoglou C, Müller-Schunk S, Weber C, Hoffmann U, Ulbig MW.
Am J Ophthalmol. 2001 Aug;132(2):270-1.
PMID: 11476698

114. [Acute papilledema. A 69-year-old patient with acute bilateral papilledema].
Kristin N, Ulbig M.
Ophthalmologe. 2001 Feb;98(2):212-3. German. No abstract available.
PMID: 11263051

115. Indocyanine green selectively stains the internal limiting membrane.
Gandorfer A, Messmer EM, Ulbig MW, Kampik A.
Am J Ophthalmol. 2001 Mar;131(3):387-8.
PMID: 11239880

116. [Imaging of vitreoretinal adhesions in the partner eye of patients with penetrating macular foramina in optical coherence tomography].
Thiel MJ, Bechmann M, Ullrich S, Gass C, Haritoglou C, Binder C, Kristin N, Lackerbauer CA, Gandorfer A, Ulbig MW.
Ophthalmologe. 2000 Dec;97(12):821-6. German.
PMID: 11227151

117. Retinal telangiectasis and angioid streaks.
Gandorfer A, Ulbig M, Bechmann M, Frölich S, Kampik A.
Br J Ophthalmol. 2000 Nov;84(11):1327-8. No abstract available.
PMID: 11203177

118. Central corneal thickness measurement with a retinal optical coherence tomography device versus standard ultrasonic pachymetry.
Bechmann M, Thiel MJ, Neubauer AS, Ullrich S, Ludwig K, Kenyon KR, Ulbig MW.
Cornea. 2001 Jan;20(1):50-4.
PMID: 11189004

119. [Ptosis, pigment dipersion and epiretinal gliosis].
Fröhlich SJ, Ulbig MW.
Ophthalmologe. 2000 Sep;97(9):648-9. German. No abstract available.
PMID: 11147342

120. [Multifactorial analysis of therapeutic outcome of pseudophakic retinal detachment surgery].
Grüterich M, Clemente C, Mueller AJ, Ulbig MW, Kampik A.
Ophthalmologe. 2000 Sep;97(9):609-14. German.
PMID: 11147333

121. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy.
Gandorfer A, Putz E, Welge-Lüssen U, Grüterich M, Ulbig M, Kampik A.
Br J Ophthalmol. 2001 Jan;85(1):6-10.
PMID: 11133703

122. Central corneal thickness determined with optical coherence tomography in various types of glaucoma.
Bechmann M, Thiel MJ, Roesen B, Ullrich S, Ulbig MW, Ludwig K.
Br J Ophthalmol. 2000 Nov;84(11):1233-7.
PMID: 11049946

123. Diffuse subretinal fibrosis syndrome.
Gandorfer A, Ulbig MW, Kampik A.
Retina. 2000;20(5):561-3. No abstract available.
PMID: 11039442

124. [Minimally invasive therapy for clinically complete central retinal artery occlusion--results and meta-analysis of literature].
Neubauer AS, Mueller AJ, Schriever S, Grüterich M, Ulbig M, Kampik A.
Klin Monbl Augenheilkd. 2000 Jul;217(1):30-6. German.
PMID: 10949814

125. Optical coherence tomography findings in early solar retinopathy.
Bechmann M, Ehrt O, Thiel MJ, Kristin N, Ulbig MW, Kampik A.
Br J Ophthalmol. 2000 May;84(5):547-8. No abstract available.
PMID: 10847708

126. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.
Gandorfer A, Messmer EM, Ulbig MW, Kampik A.
Retina. 2000;20(2):126-33.
PMID: 10783944

127. [Diabetic retinopathy--screening is a requirement. Don't wait until vision becomes impaired].
Gandorfer A, Ulbig M.
MMW Fortschr Med. 2000 Mar 30;142(13):26-9. German.
PMID: 10783619

128. [Photo essay. Progressive vision diminution and metamorphopsias. Bilateral vision diminution and metamorphopsia in a 50-year-old patient].
Gandorfer A, Ulbig M, Kampik A.
Ophthalmologe. 1999 Oct;96(10):684-5. German. No abstract available.
PMID: 10552165

129. [What is the value of transpupillary thermotherapy in treatment of flat posterior choroid melanomas? A systematic review of the literature?].
Grüterich M, Mueller AJ, Ulbig M, Kampik A.
Klin Monbl Augenheilkd. 1999 Sep;215(3):147-51. Review. German.
PMID: 10528278

130. [Ophthalmological screening studies in newborn infants. German Ophthalmological Society].
Clemens S, Eckardt C, Gerding H, Grote A, Jandeck C, Kellner U, Lorenz B, Petersen J, Seiberth V, Stärk N, Ulbig MW, Zubcov A, Jorch G, Pohlandt F.
Ophthalmologe. 1999 Apr;96(4):257-63. German. No abstract available.
PMID: 10409854

131. [Sudden loss of vision without previous symptoms. 58-year-old patient with sudden and painless loss of vision of the right eye].
Fröhlich SJ, Ulbig MW, Klauss V.
Ophthalmologe. 1999 Feb;96(2):120-1. German. No abstract available.
PMID: 10095360

132. Long-term results after drainage of premacular subhyaloid hemorrhage into the vitreous with a pulsed Nd:YAG laser.
Ulbig MW, Mangouritsas G, Rothbacher HH, Hamilton AM, McHugh JD.
Arch Ophthalmol. 1998 Nov;116(11):1465-9.
PMID: 9823347

133. [Bilateral unclear papilledema].
Grasbon T, Möhring C, Ulbig MW.
Ophthalmologe. 1998 Sep;95(9):652-3. German. No abstract available.
PMID: 9793389

134. [North Carolina macular dystrophy. Hereditary macular disease with good functional prognosis].
Schworm HD, Ulbig MW, Hoops J, Rudolph G, Weber BH, Ehrt O, Boergen KP.
Ophthalmologe. 1998 Jan;95(1):13-8. German.
PMID: 9531796

135. An ancestral core haplotype defines the critical region harbouring the North Carolina macular dystrophy gene (MCDR1).
Sauer CG, Schworm HD, Ulbig M, Blankenagel A, Rohrschneider K, Pauleikhoff D, Grimm T, Weber BH.
J Med Genet. 1997 Dec;34(12):961-6.
PMID: 9429134

136. Diode laser contact transscleral retinal photocoagulation: a clinical study.
McHugh DA, Schwartz S, Dowler JG, Ulbig M, Blach RK, Hamilton PA.
Br J Ophthalmol. 1995 Dec;79(12):1083-7.
PMID: 8562540

137. Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes.
Ulbig MW, Wolfensberger TJ, Hiscott P, Ationu A, Carter ND, Gregor ZJ.
Ger J Ophthalmol. 1995 Sep;4(5):264-8.
PMID: 7496335

138. Clinical comparison of semiconductor diode versus neodymium: YAG non-contact cyclo photocoagulation.
Ulbig MW, McHugh DA, McNaught AI, Hamilton AM.
Br J Ophthalmol. 1995 Jun;79(6):569-74.
PMID: 7626573

139. Diode laser photocoagulation for diabetic macular oedema.
Ulbig MW, McHugh DA, Hamilton AM.
Br J Ophthalmol. 1995 Apr;79(4):318-21.
PMID: 7742274

140. [Risk factors for surgical failures in rhegmatogenous retinal detachment].
Mangouritsas G, Rothbächer HH, Heidenkummer PH, Ulbig MW, Kampik A.
Klin Monbl Augenheilkd. 1995 Jan;206(1):20-8. German.
PMID: 7897964

141. [Iris neovascularization, increased intraocular pressure and vitreous hemorrhage as risk factors for invasion of the optic nerve and choroid in children with retinoblastoma].
Baez KA, Ulbig MW, Cater J, Shields CL, Shields JA.
Ophthalmologe. 1994 Dec;91(6):796-800. German.
PMID: 7849434

142. Long-term results of ab externo neodymium:YAG cyclophotocoagulation.
Baez KA, Ulbig MW, McHugh D, Holz FW, Spaeth GL.
Ger J Ophthalmol. 1994 Nov;3(6):395-9.
PMID: 7866258

143. Contact diode laser cyclo-photocoagulation for refractory glaucoma. A pilot study.
Ulbig MW, McHugh D, McNaught A, Hamilton P.
Ger J Ophthalmol. 1994 Aug;3(4-5):212-5.
PMID: 7804105

144. [Diagnosis and therapy of glaucoma in early childhood].
Bäz KA, Ulbig MW, Rice NS.
Ophthalmologe. 1994 Jun;91(3):408-18. German. No abstract available.
PMID: 8086763

145. Color contrast sensitivity and pattern electroretinographic findings after diode and argon laser photocoagulation in diabetic retinopathy.
Ulbig MR, Arden GB, Hamilton AM.
Am J Ophthalmol. 1994 May 15;117(5):583-8.
PMID: 8172263

146. Cotton-wool spots as the initial ocular manifestation in Wegener's granulomatosis.
Mangouritsas G, Ulbig M.
Ger J Ophthalmol. 1994 Mar;3(2):68-70.
PMID: 8193574

147. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.
Ulbig MR, Riordan-Eva P, Holz FG, Rees HC, Hamilton PA.
Am J Ophthalmol. 1993 Oct 15;116(4):410-3.
PMID: 8213970

148. [Comparative use of diode and argon laser for panretinal photocoagulation in diabetic retinopathy].
Ulbig MW, Hamilton AM.
Ophthalmologe. 1993 Oct;90(5):457-62. German.
PMID: 8219631

149. [Stage-related therapy of diabetic retinopathy].
Ulbig MW, Kampik A.
Ophthalmologe. 1993 Aug;90(4):395-44. Review. German. No abstract available.
PMID: 8374241

150. [Does combined pancreas-kidney transplantation modify diabetic retinopathy in type-1 diabetic patients?].
Meyer-Schwickerath E, Scheider A, Thurau SR, Ulbig M, Landgraf R, Kampik A, Land W.
Ophthalmologe. 1993 Jun;90(3):283-8. German.
PMID: 8334333

151. [Diabetic retinopathy. Epidemiology, risk factors and staging].
Ulbig MW, Kampik A, Hamilton AM.
Ophthalmologe. 1993 Apr;90(2):197-209. Review. German. No abstract available.
PMID: 8490306

152. Photocoagulation of choroidal neovascular membranes with a diode laser.
Ulbig MW, McHugh DA, Hamilton AM.
Br J Ophthalmol. 1993 Apr;77(4):218-21.
PMID: 7684256

153. Anterior hyaloidal fibrovascular proliferation after extracapsular cataract extraction in diabetic eyes.
Ulbig MR, Hykin PG, Foss AJ, Schwartz SD, Hamilton PA.
Am J Ophthalmol. 1993 Mar 15;115(3):321-6.
PMID: 7680186

154. Factors influencing the natural history of diabetic retinopathy.
Ulbig MR, Hamilton AM.
Eye (Lond). 1993;7 ( Pt 2):242-9. Review.
PMID: 7607343

155. The eye in diabetes.
Hamilton A, Ulbig M.
Practitioner. 1991 Oct;235(1507):780-2. Review. No abstract available.
PMID: 1800984

156. [Secondary angle-block glaucoma in posterior scleritis].
Mangouritsas G, Ulbig M.
Klin Monbl Augenheilkd. 1991 Jun;199(1):40-4. German.
PMID: 1895739

157. [Diagnostic and functional significance of arcus lipoides in hypercholesterolemia].
Schneider T, Ulbig M.
Fortschr Ophthalmol. 1991;88(1):21-4. German.
PMID: 2045021

158. Long-term follow-up of diabetic retinopathy for up to 71 months after combined renal and pancreatic transplantation.
Ulbig M, Kampik A, Thurau S, Landgraf R, Land W.
Graefes Arch Clin Exp Ophthalmol. 1991;229(3):242-5.
PMID: 1869059

159. [Absence of cataractogenic effect of lovastatin (Mevinacor) so far].
Ulbig M, Schneider T.
Fortschr Ophthalmol. 1991;88(5):431-3. German.
PMID: 1757025

160. [Vitrectomy in proliferative diabetic retinopathy. Preoperative factors for surgical procedure and postoperative results].
Ulbig M, Kampik A, Heidenkummer HP.
Fortschr Ophthalmol. 1990;87(5):443-8. German.
PMID: 2272571

161. [Pars plana vitrectomy in chronic uveitis in the child].
Ulbig M, Kampik A.
Klin Monbl Augenheilkd. 1989 Jan;194(1):10-2. German.
PMID: 2709732

162. [The pancreatic graft and its impact on late complications of diabetes mellitus].
Landgraf R, Nusser J, Landgraf-Leurs MM, Muller W, Thurau S, Kampik A, Ulbig M, Abendroth D, Illner WD, Land W.
Journ Annu Diabetol Hotel Dieu. 1989:133-8. Review. French. No abstract available.
PMID: 2668608

163. Fate of late complications in type I diabetic patients after successful pancreas-kidney transplantation.
Landgraf R, Nusser J, Müller W, Landgraf-Leurs MM, Thurau S, Ulbig M, Kampik A, Lachenmayr B, Hillebrand G, Schleibner S, et al.
Diabetes. 1989 Jan;38 Suppl 1:33-7.
PMID: 2642853

164. [Functional and morphologic variations in fundus flavimaculatus].
Ulbig M, Zrenner E, Schneider T.
Fortschr Ophthalmol. 1988;85(3):312-6. German. No abstract available.
PMID: 3209163

165. Functional and morphological variations of fundus flavimaculatus.
Ulbig M, Zrenner E, Schneider T.
Doc Ophthalmol. 1987 Dec;67(4):315-26.
PMID: 3454315

166. The influence of combined pancreatic and renal transplantation on advanced diabetic retinopathy.
Ulbig M, Kampik A, Landgraf R, Land W.
Transplant Proc. 1987 Oct;19(5):3554-6. No abstract available.
PMID: 3313856